Home
January 2010 February 2010 March 2010
Su Mo Tu We Th Fr Sa
Week 5 1 2 3 4 5 6
Week 6 7 8 9 10 11 12 13
Week 7 14 15 16 17 18 19 20
Week 8 21 22 23 24 25 26 27
Week 9 28
Reach urologists

Incidence of Testicular Germ Cell Cancers in U.S. Children: SEER Program Experience 1973 to 2000 Show Comments PDF Print E-mail
  
Tuesday, 12 December 2006
BERKELEY, CA (UroToday.com) - It has been reported that the incidence of testicular cancer in the Caucasian population in the United States increased during most of the last half of the 20th Century, but information on trends in the occurrence of prepubertal testicular cancer is lacking in the literature.

 Walsh, et al, from Seattle, Washington analyzed the population-based cohort to determine whether the incidence trends of prepubertal testicular germ cell tumors have risen similarly to those seen in the adult testicular tumors. They identified cases of histological confirmed germ cell cancer in boys from the newborn period to 14 years of age, of all races, over a period from 1973-2000. They performed a study the Surveillance, Epidemiology, and End Results program of the National Cancer Institute. The variable analyzed included age, race, tumor histological type, and year of diagnosis.

The group found that a total of 131 cases of germ cell cancer were diagnosed among boys of all races, with an overall incidence of 1.6 cases per 1 million person-years. Yolk sac tumor was the most common, followed by teratoma. Choriocarcinoma and seminoma were equally rare. Tumors were most common among Caucasians during early infancy. No secular trends in incidence rates were identified.

The group concluded that prepubertal testicular cancer is rare. All tumors were more common in Caucasians. In contrast to adult testicular cancer, no clear trend over time was found for prepubertal tumors. Whatever the etiology may be for the increased incidence of testicular cancer over time in men, it does not seem to apply to testicular cancer in boys.

Walsh TJ, Grady RW, Porter MP, Lin DW, Weiss NS

Urology 68(2):402-405,2006

Written by Pasquale Casale, MD, a Contributing Editor with UroToday.

Reader Comments

Please log-in or register in order to submit comments.

Powered by AkoComment!

 
User Rating: / 0
PoorBest


 

Bookmark and Share
< Prev   Next >

Member's Section

Login

Sign Up

Quick Search

Meet the Expert


All Experts



Featured Conference

Media and Publisher

Advertising Rates

Working with Industry

Case Studies
Sponsorship Opportunities

Testicular Cancer
Sponsored By